NCT01993706View on ClinicalTrials.gov

Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

November 19, 2013

Primary Completion Date

February 27, 2015

Study Completion Date

February 27, 2015

Conditions
HIV InfectionMonoclonal Antibody, HumanHIV AntibodiesVRC01 Monoclonal AntibodyNeutralizing Antibody
Interventions
DRUG

VRC-HIVMAB060-00-AB

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT01993706 - Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults | Biotech Hunter | Biotech Hunter